Search Page

1

Cite

Share

AGO Score As a Predictor of Surgical Outcome at Secondary Cytoreduction in Patients with Ovarian Cancer.

Muallem MZ, Gasimli K, Richter R, Almuheimid J, Nasser S, Braicu EI, Sehouli J. Muallem MZ, et al. Among authors: gasimli k. Anticancer Res. 2015 Jun;35(6):3423-9. Anticancer Res. 2015. PMID: 26026105 Clinical Trial.

Cite

Share

2

Cite

Share

Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer.

Muallem MZ, Sehouli J, Richter R, Babayeva A, Gasimli K, Parashkevova A. Muallem MZ, et al. Among authors: gasimli k. Int J Gynecol Cancer. 2020 Jan;30(1):62-66. doi: 10.1136/ijgc-2019-000778. Epub 2019 Nov 19. Int J Gynecol Cancer. 2020. PMID: 31744887

Cite

Share

3

Cite

Share

Clinical Outcome After Completion Surgery in Patients With Ovarian Cancer: The Charite Experience.

Babayeva A, Braicu EI, Grabowski JP, Gasimli K, Richter R, Muallem MZ, Sehouli J. Babayeva A, et al. Among authors: gasimli k. Int J Gynecol Cancer. 2018 Oct;28(8):1491-1497. doi: 10.1097/IGC.0000000000001328. Int J Gynecol Cancer. 2018. PMID: 30095708

Cite

Share

4

Cite

Share

Is endometrial cancer really a neurophobic tumor? A case report and review of the literature.

Nassir M, Roth A, Gasimli K, Braicu EI, Fotopoulou C, Mawrin C, Badakhshi H, Warnke JP, Sehouli J. Nassir M, et al. Among authors: gasimli k. Anticancer Res. 2014 Jan;34(1):249-57. Anticancer Res. 2014. PMID: 24403471 Review.

Cite

Share

5

Cite

Share

Claudin-1 is linked to presence of implants and micropapillary pattern in serous borderline epithelial tumours of the ovary.

El-Balat A, Schmeil I, Gasimli K, Sänger N, Karn T, Ahr A, Becker S, Arsenic R, Holtrich U, Engels K. El-Balat A, et al. Among authors: gasimli k. J Clin Pathol. 2018 Dec;71(12):1060-1064. doi: 10.1136/jclinpath-2018-205292. Epub 2018 Aug 31. J Clin Pathol. 2018. PMID: 30171086

Cite

Share

6

Cite

Share

Impact of re-excision of residual adjacent vulvar intraepithelial neoplasia (VIN III) and histological tumour-free margin (hTFM) on survival in primary squamous cell carcinoma of vulva.

Gasimli K, Straussner M, Schmeil I, Karn T, Winkelmann R, Becker S, El-Balat A. Gasimli K, et al. Arch Gynecol Obstet. 2018 Nov;298(5):945-950. doi: 10.1007/s00404-018-4887-1. Epub 2018 Sep 6. Arch Gynecol Obstet. 2018. PMID: 30187190

Cite

Share

7

Cite

Share

Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer.

Gasimli K, Braicu EI, Richter R, Chekerov R, Sehouli J. Gasimli K, et al. Ann Surg Oncol. 2015 Aug;22(8):2729-37. doi: 10.1245/s10434-014-4329-7. Epub 2015 Feb 12. Ann Surg Oncol. 2015. PMID: 25672560

Cite

Share

8

Cite

Share

Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.

Gasimli K, Braicu EI, Nassir M, Richter R, Babayeva A, Chekerov R, Darb-Esfahani S, Sehouli J, Muallem MZ. Gasimli K, et al. Ann Surg Oncol. 2016 Apr;23(4):1279-86. doi: 10.1245/s10434-015-4959-4. Epub 2016 Jan 29. Ann Surg Oncol. 2016. PMID: 26832880

Cite

Share

9

Cite

Share

Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer--results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial.

Braicu EI, Gasimli K, Richter R, Nassir M, Kümmel S, Blohmer JU, Yalcinkaya I, Chekerov R, Ignat I, Ionescu A, Mentze M, Fotopoulou C, Pop C, Lichtenegger W, Sehouli J; Tumor Bank Ovarian Cancer (TOC); German North Eastern Society for Gynecological Oncology (NOGGO). Braicu EI, et al. Among authors: gasimli k. Anticancer Res. 2014 Jan;34(1):385-91. Anticancer Res. 2014. PMID: 24403492 Clinical Trial.

Cite

Share

10

Cite

Share

Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) - a study of the TOC Consortium.

Braicu EI, Van Gorp T, Nassir M, Richter R, Chekerov R, Gasimli K, Timmerman D, Vergote I, Sehouli J. Braicu EI, et al. Among authors: gasimli k. J Ovarian Res. 2014 May 7;7:49. doi: 10.1186/1757-2215-7-49. eCollection 2014. J Ovarian Res. 2014. PMID: 24872845 Free PMC article.

Cite

Share